Available from: report_2025_web
By contrast, only one in 20 (5.1%) men said they would likely consider using weight loss medications in the next year
It is a dual GIP and GLP-1 receptor agonist.14 This means it mimics the actions of both GLP-1 and another incretin hormone called glucose-dependent insulinotropic polypeptide (GIP)
This dual-action approach mimics how your body naturally regulates appetite and blood sugar, making it more effective for sustainable weight loss
PlexusDx Compounded Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan) flat, regardless of dose level
Were going to go through the actual science, the specific risks that apply to those with hypermobility and EDS, the evidence for fibromyalgia specifically, and the honest practical picture, because there is genuinely interesting stuff here alongside some real reasons for caution